Treatment with the direct oral anticoagulants (DOACs) apixaban and rivaroxaban associated with significant worsening of behavioural and psychological symptoms of dementia (BPSD)

Mostrar otras versiones (1)

We report the cases of two patients who developed worsening behavioural and psychological symptoms of dementia (BPSD), coinciding with starting the factor Xa inhibitor direct oral anticoagulant medications apixaban and rivaroxaban, respectively. Both patients required detaining under the Mental Heal...

Descripción completa

Detalles Bibliográficos
Autores principales: Porter, Kim Maria Frances, Hargreaves, Iain Parry, De Souza, Stephen, Goddard, Rebecca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7942237/
https://www.ncbi.nlm.nih.gov/pubmed/33685912
http://dx.doi.org/10.1136/bcr-2020-240059

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7942237/
https://www.ncbi.nlm.nih.gov/pubmed/33685912
http://dx.doi.org/10.1136/bcr-2020-240059

Ejemplares similares